Search Results - eric+schopf

2 Results Sort By:
EGFRvIII Antibodies for the Treatment of Human Cancer
Summary: The NCI seeks research co-development partners or licensees for monoclonal antibodies that specifically target cancer-expressed EGFR. Description of Technology: Epidermal growth factor receptor variant III (EGFRvIII) is a variant of EGFR that is an excellent target for immunotherapy because of its expression in cancer cells and not in normal...
Published: 4/24/2026   |   Updated: 8/2/2023   |   Inventor(s): David Fitzgerald, Antonella Antignani, Eric Ho, Robert Sarnovsky
Keywords(s): ADC, Antibody-drug Conjugate, CAR, chimeric antigen receptor, EGFR, EGFRvIII, Epidermal Growth Factor Receptor, Epidermal growth factor receptor variant III, FitzGerald, Recombinant Immunotoxins, RITs
Category(s): Application > Therapeutics, TherapeuticArea > Oncology, Collaboration Sought > Collaboration, Collaboration Sought > Licensing
2017-210 AUTOMATED PURIFICATION AND FORMULATION MODULE FOR PET PROBES
INTRO SENTENCE: Sofie Biosciences and UCLA researchers from the Department of Molecular and Medical Pharmacology have developed a novel automated module that purifies and formulates radiolabeled compounds intended for medical use. This automation reduces labor cost and radiation exposure, and is widely applicable.TITLE: Automated Purification...
Published: 7/17/2025   |   Updated: 9/11/2019   |   Inventor(s): Michael van Dam, Melissa Moore, Eric Schopf, Brandon Maraglia, Alexander Hsiao
Keywords(s):  
Category(s): Medical Devices > Medical Imaging > PET